JMIR Mental Health
June 12, 2024
Camrie Kerry, Prabhdeep Mann, Nazanin Babaei et al.
4 citations
Internet-based cognitive behavioral therapy (CBT) and stand-alone mindfulness meditation interventions are gaining empirical support for a wide variety of mental health conditions. In this study, we test the efficacy of web-based therapist-guided mindfulness-based cognitive behavioral therapy (CBT-M) for body dysmorphic disorder (BDD), a psychiatric disorder characterized by preoccupations with...
Toxicology Letters
June 12, 2024
Joachim Neumann, Kiril Dimov, Karyna Azatsian et al.
5 citations
Several fungi belonging to the genus Psilocybe, also called "magic mushrooms", contain the hallucinogenic drugs psilocybin and psilocin. They are chemically related to serotonin (5-HT). In addition to being abused as drugs, they are now also being discussed or used as a treatment option for depression. Here, we hypothesized that psilocybin and psilocin may act also on cardiac serotonin...
The Journal of Headache and Pain
June 11, 2024
Davide Fedeli, Giuseppe Ciullo, Greta Demichelis et al.
17 citations
Mindfulness practice has gained interest in the management of Chronic Migraine associated with Medication Overuse Headache (CM-MOH). Mindfulness is characterized by present-moment self-awareness and relies on attention control and emotion regulation, improving headache-related pain management. Mindfulness modulates the Default Mode Network (DMN), Salience Network (SN), and Fronto-Parietal...
Frontiers in Psychiatry
June 10, 2024
Leehe Peled-Avron, Jacob S. Aday, Amilia Lydia Kalafateli et al.
2 citations
Editorial on the Research Topic Down the rabbit hole -the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions Psychedelic substances have demonstrated promising therapeutic effects across a wide range of mental health conditions including depression (1-13) anxiety disorders including generalized anxiety (14-16) and social...
Nature Communications
June 10, 2024
Andiara E Freitas, Bo Feng, Timothy Woo et al.
9 citations
Single administration of low-dose ketamine has both acute and sustained anti-depressant effects. Sustained effect is associated with restoration of glutamatergic synapses in medial prefrontal cortic (mFPC) neurons. Ketamine induced profound changes in a number of molecular pathways in a mouse model for chronic stress. Cell-cell communication analyses predicted that planar-cell-polarity (PCP)...
Journal of Telenursing
June 8, 2024
Ermelinda Toyo Legu, Dewi Gayatri, Agung Waluyo
This research aims to determine the effectiveness of mindfulness-based cognitive therapy in reducing anxiety in cancer patients. The research method used is a systematic review, searching articles in six trusted databases: ProQuest, EBSCOhost, PubMed, Wiley Online Library, SpringerLink, and Google Scholar—article analysis using the PRISMA method. The research results show that mindfulness-based...
UNC Libraries
June 7, 2024
Kami Kim, Tao Che, Ouliana Panova et al.
Hallucinogens like lysergic acid diethylamide (LSD), psilocybin, and substituted N-benzyl phenylalkylamines are widely used recreationally with psilocybin being considered as a therapeutic for many neuropsychiatric disorders including depression, anxiety, and substance abuse. How psychedelics mediate their actions—both therapeutic and hallucinogenic—are not understood, although activation of...
Research Square
June 7, 2024
Målin Schmidt, Anne Hoffrichter, Mahnaz Davoudi et al.
5 citations
preprint
Abstract Psilocybin is studied as innovative medication in anxiety, substance abuse and treatment-resistant depression. Animal studies show that psychedelics promote neuronal plasticity by strengthening synaptic responses and protein synthesis. However, the exact molecular and cellular changes induced by psilocybin in the human brain are not known. Here, we treated human cortical neurons...
Psychiatria
June 5, 2024
Anna Stankiewicz, Jan Szewczyk, Julia Truszkowska et al.
1 citation
Drug therapies for many psychiatric conditions do not meet patients’ expectations. New agents are being sought to treat depression and anxiety disorders, among others. Scientific interest in psychoactive substances has increased over the past few decades. Recent studies provide evidence that psychedelics may find use in the treatment of a range of mental disorders. This paper describes new...
International Journal of Linguistics Applied Psychology and Technology
June 4, 2024
Dr. Anita Sagar
Mental wellness has emerged as one of the most critical components of public health and human development in the twenty-first century. As global societies confront rising levels of stress, anxiety, depression, and psychological fragmentation, there is a growing interest in integrative frameworks that explore the role of subtle influences on mental states. Microvita, a concept introduced by the...